Pilot scorecard
Florastor scored 5 out of 6 for label disclosure under methodology v1.13, read from the label as captured on 2026-09-26.
100ct variant, Amazon listing B01NB0G1V8.
The single active carries an exact amount, Saccharomyces boulardii CNCM I-745 500 mg. No proprietary blend on the panel.
No standardization-dependent ingredient in the formula.
CNCM I-745 is a culture depositary designation (Collection Nationale de Cultures de Microorganismes), not a species name or a marketing name.
Under methodology v1.12, the first product in the sample to take this point. The panel declares 500 mg of preparation rather than CFU, so the probiotic unit mismatch does not arise, and 500 mg falls at the floor of the 500-1000 mg/day range set by independent adult trials of this strain (Seddik 2019 PMID 30694338; Sjomina 2023 PMID 37942999; Salazar-Parra 2023 PMID 37400812). Maev 2025 excluded from setting the range under the independence rule: it dosed Enterol, a Biocodex product, and Biocodex manufactures Florastor. The outcome objection is published alongside the v1.12 ruling.
No publicly accessible third-party certificate of analysis located 2026-09-26. The search covered the 10 listing images, florastor.com navigation and footer (no Quality, Testing, Lab Results or Transparency link exists), the florastor.com FAQ page, and a site-scoped web search for 'certificate of analysis'. Recorded as a negative finding, not a claim that none exists.
Serving size 2 capsules and servings per container 50 are both printed on the panel. First product in the sample to take this point.
Scores are read from the live label, captured by screenshot on the date shown. A score describes what the label discloses. It says nothing about whether the product works, and nothing here was lab-tested.
